US Patent

US9283280 — Compositions for drug administration

Formulation · Assigned to Aegis Therapeutics LLC · Expires 2026-05-09 · 0y expired

Vulnerability score 45/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects compositions that combine an alkyl glycoside with a therapeutic agent, such as a 5-HT receptor agonist, to increase bioavailability and provide migraine pain relief.

USPTO Abstract

The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject, as well as compositions and methods for providing migraine pain relief. The compositions include at least one alkyl glycoside and at least one therapeutic agent, such as a 5-HT receptor agonist, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.

Drugs covered by this patent

Patent Metadata

Patent number
US9283280
Jurisdiction
US
Classification
Formulation
Expires
2026-05-09
Drug substance claim
No
Drug product claim
Yes
Assignee
Aegis Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.